Literature DB >> 31804859

Valuing Chimeric Antigen Receptor T-Cell Therapy: Current Evidence, Uncertainties, and Payment Implications.

Melanie D Whittington1, R Brett McQueen1, Jonathan D Campbell1.   

Abstract

Year:  2019        PMID： 31804859     DOI： 10.1200/JCO.19.01558

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Economic Evidence on Potentially Curative Gene Therapy Products: A Systematic Literature Review.

Authors:  Joseph Khoa Ho; Kennedy Borle; Nick Dragojlovic; Manrubby Dhillon; Vanessa Kitchin; Nicola Kopac; Colin Ross; Larry D Lynd
Journal:  Pharmacoeconomics       Date:  2021-06-22       Impact factor: 4.981

2.  Weighing Costs and Benefits in the Economics of Cancer Care.

Authors:  Scott D Ramsey; Stacie B Dusetzina
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

3.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

Review 4.  Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments.

Authors:  Xinjie Xu; Shengkang Huang; Xinyi Xiao; Qihang Sun; Xiaoqian Liang; Sifei Chen; Zijing Zhao; Zhaochang Huo; Sanfang Tu; Yuhua Li
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

Review 5.  The impact of COVID-19 on the cell and gene therapies industry: disruptions, opportunities, and future prospects.

Authors:  Tingting Qiu; Yitong Wang; Shuyao Liang; Ru Han; Mondher Toumi
Journal:  Drug Discov Today       Date:  2021-04-20       Impact factor: 7.851

6.  Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy.

Authors:  Gyeyoung Choi; Gyeongseon Shin; SeungJin Bae
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.